Atlas Trials

Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT

Clinical trial NCT03068403 · TERMINATED

Trial details

NCT number
NCT03068403
Sponsor
University Hospital, Bordeaux
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2018-06-18
Primary completion
2018-11-08
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.